Submission Deadlines

• Submission portal opens: Monday, Sept. 15
• Submission deadline: Friday, Sept. 25
• Embargo Lift: Thursday, Nov. 5 at 8 AM MT
  • View the embargo policy

Contact education@aasld.org, for questions regarding criteria, submission process, or general information. 

Submission Details

• Statement: All submissions must include an author statement explaining the basis for eligibility in the clinician or laboratory-based category.
• Disclosures: Presenting authors are required to submit disclosures.  Please collect disclosures before beginning the submission process.

Submission Criteria

Original late-breaking scientific research conducted and submitted after the original abstract deadline of May 28, 2026 will be considered. Abstracts are considered late-breaking if they meet the following criteria:

1. Research must be new and of sufficient scientific importance to merit special consideration. 
2. Retrospective studies are not eligible.
3. Submissions should describe either large clinical studies or high-impact translational research that could not be completed prior to the original deadline.
4. Clinical studies must be prospective in design.
   1. Authors must provide documentation for late consideration with the closure date of the study.
      1. The date must be after March 2, 2026 or 12 weeks before the closure of the abstract submission.
      2. Phase 1 trials will be considered, but only in poster format.
5. Phase 2/3 trials will be considered for an oral or poster presentation. 
6. Laboratory-based studies are generally not considered for late submissions and must be strongly justified. 
   1. Authors must explain why the research could not be submitted by the regular abstract deadline.
7. Late-breaking abstracts cannot be:
   1. A revision of an abstract submitted during the regular abstract submission timeline.
   2. Presented, accepted, or published in any other scientific venue.

View the Embargo Policy